Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons | The BMJ
Treatment Considerations | XARELTO® (rivaroxaban) HCP
Guidance on converting between anticoagulants
Safety Profile - DVT & PE Initial Treatment | XARELTO® (rivaroxaban) HCP
Aspirin and an oral anticoagulant – can they be used together? - NPS MedicineWise
Pharmacokinetic and pharmacodynamic evaluation of rivaroxaban: considerations for the treatment of venous thromboembolism | Thrombosis Journal | Full Text
Transition of Anticoagulants 2014
Xarelto® Rivaroxaban The first oral direct factor Xa inhibitor - ppt download
New Oral Anticoagulants: A Review - ppt video online download
Transition of Anticoagulants 2016
Anticoagulants | Health Navigator NZ
RBCP - Cost comparison between enoxaparin and new oral anticoagulants dabigatran and rivaroxaban in venous thromboembolism prophylaxis
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges | Journal of the American Heart Association
Anticoagulation Strategies in Patients With Cancer: JACC Review Topic of the Week - ScienceDirect
Care Transitions in Anticoagulation Management for Patients With Atrial Fibrillation: An Emphasis on Safety | Ochsner Journal
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges | Journal of the American Heart Association
Dose of XARELTO for Switching From Another Anticoagulant During Initial DVT or PE Treatment
How to switch from rivaroxaban to LMWH? | Download Scientific Diagram
How to switch from rivaroxaban to LMWH? | Download Scientific Diagram
Oral anticoagulants in the management of venous thromboembolism | Nature Reviews Cardiology
Rivaroxaban: a fully-subsidised oral anticoagulant
Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials -
Cureus | Current Trends in the Duration of Anticoagulant Therapy for Venous Thromboembolism: A Systematic Review
Updated Guidelines on Outpatient Anticoagulation | AAFP
Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation - ScienceDirect
